192 related articles for article (PubMed ID: 29055600)
1. Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy.
Chatterjee D; Moore C; Gao B; Clerkin KJ; See SB; Shaked D; Rogers K; Nunez S; Veras Y; Addonizio L; Givertz MM; Naka Y; Mancini D; Vasilescu R; Marboe C; Restaino S; Madsen JC; Zorn E
J Heart Lung Transplant; 2018 Mar; 37(3):385-393. PubMed ID: 29055600
[TBL] [Abstract][Full Text] [Related]
2. Immunological and Fibrotic Mechanisms in Cardiac Allograft Vasculopathy.
Jansen MA; Otten HG; de Weger RA; Huibers MM
Transplantation; 2015 Dec; 99(12):2467-75. PubMed ID: 26285017
[TBL] [Abstract][Full Text] [Related]
3. The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy.
Huibers MM; Gareau AJ; Vink A; Kruit R; Feringa H; Beerthuijzen JM; Siera-de Koning E; Peeters T; de Jonge N; de Weger RA; Lee TD
J Heart Lung Transplant; 2015 May; 34(5):734-45. PubMed ID: 25655346
[TBL] [Abstract][Full Text] [Related]
4. Effector B cells in cardiac allograft vasculopathy.
Zorn E
Curr Opin Organ Transplant; 2019 Feb; 24(1):31-36. PubMed ID: 30480642
[TBL] [Abstract][Full Text] [Related]
5. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.
Wu GW; Kobashigawa JA; Fishbein MC; Patel JK; Kittleson MM; Reed EF; Kiyosaki KK; Ardehali A
J Heart Lung Transplant; 2009 May; 28(5):417-22. PubMed ID: 19416767
[TBL] [Abstract][Full Text] [Related]
7. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
8. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.
Nath DS; Ilias Basha H; Tiriveedhi V; Alur C; Phelan D; Ewald GA; Moazami N; Mohanakumar T
J Heart Lung Transplant; 2010 Nov; 29(11):1277-85. PubMed ID: 20615726
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
[TBL] [Abstract][Full Text] [Related]
10. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
[TBL] [Abstract][Full Text] [Related]
11. Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study.
Huibers MM; Vink A; Kaldeway J; Huisman A; Timmermans K; Leenders M; Schipper ME; Lahpor JR; Kirkels HJ; Klöpping C; de Jonge N; de Weger RA
Atherosclerosis; 2014 Oct; 236(2):353-9. PubMed ID: 25128973
[TBL] [Abstract][Full Text] [Related]
12. Cardiac allograft vasculopathy: a donor or recipient induced pathology?
van den Hoogen P; Huibers MM; Sluijter JP; de Weger RA
J Cardiovasc Transl Res; 2015 Mar; 8(2):106-16. PubMed ID: 25652948
[TBL] [Abstract][Full Text] [Related]
13. Rantes production during development of cardiac allograft vasculopathy.
Yun JJ; Fischbein MP; Laks H; Irie Y; Espejo ML; Fishbein MC; Berliner JA; Ardehali A
Transplantation; 2001 Jun; 71(11):1649-56. PubMed ID: 11435978
[TBL] [Abstract][Full Text] [Related]
14. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
Husain AN; Mirza KM; Fedson SE
J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
[TBL] [Abstract][Full Text] [Related]
15. Cardiac allograft vasculopathy: real or a normal morphologic variant?
Houser S; Muniappan A; Allan J; Sachs D; Madsen J
J Heart Lung Transplant; 2007 Feb; 26(2):167-73. PubMed ID: 17258151
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen class I antibody-activated endothelium promotes CD206+ M2 macrophage polarization and MMP9 secretion through TLR4 signaling and P-selectin in a model of antibody-mediated rejection and allograft vasculopathy.
Nevarez-Mejia J; Jin YP; Pickering H; Parmar R; Valenzuela NM; Sosa RA; Heidt S; Fishbein GA; Rozengurt E; Baldwin WM; Fairchild RL; Reed EF
Am J Transplant; 2024 Mar; 24(3):406-418. PubMed ID: 38379280
[TBL] [Abstract][Full Text] [Related]
17. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
[TBL] [Abstract][Full Text] [Related]
18. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.
Atkinson C; Horsley J; Rhind-Tutt S; Charman S; Phillpotts CJ; Wallwork J; Goddard MJ
J Heart Lung Transplant; 2004 Apr; 23(4):427-35. PubMed ID: 15063402
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific antibodies are associated with micro- and macrovascular coronary disease, restrictive myocardial damage, and poor outcome in heart-transplanted patients.
Clemmensen TS; Koefoed-Nielsen P; Jensen LA; Poulsen SH; Holm NR; Løgstrup BB; Christiansen EH; Dijkstra J; Valen KPB; Eiskjaer H
Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28627046
[TBL] [Abstract][Full Text] [Related]
20. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts.
Lu WH; Palatnik K; Fishbein GA; Lai C; Levi DS; Perens G; Alejos J; Kobashigawa J; Fishbein MC
J Heart Lung Transplant; 2011 Sep; 30(9):1044-50. PubMed ID: 21640617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
